Calcium carbonate/hyaluronic acid compound medicine carrier and preparing method thereof
A technology of hyaluronic acid and calcium carbonate, which is applied in drug combinations, pharmaceutical formulations, peptide/protein components, etc., can solve the problems of complex structure and unreliable insulin loading, and achieve the advantages of simple preparation method, improved drug efficacy, and reduced trauma. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] The preparation method of the calcium carbonate / hyaluronic acid composite insulin drug carrier of the present embodiment comprises the following steps:
[0028] (1) Sodium carbonate is dissolved in deionized water, and preparation obtains the sodium carbonate solution that carbonate ion concentration is 0.1mol / L; Calcium chloride is dissolved in deionized water, and preparation obtains calcium ion concentration and is the chlorine of 0.12mol / L Calcium solution, ready for use after preparation;
[0029] (2) dissolving folic acid-modified hyaluronic acid in deionized water to prepare a hyaluronic acid solution with a mass percentage of 1%, and prepare it for later use;
[0030] (3) dissolving insulin in a buffered aqueous solution with pH=2.0, preparing an insulin solution with a concentration of 0.01mol / L, and then adjusting the pH of the insulin solution to 8.0 through the buffer;
[0031] (4) Prepare the oil phase containing surfactant, disperse surfactant sorbitan fa...
Embodiment 2
[0037] The preparation method of the calcium carbonate / hyaluronic acid composite insulin drug carrier of the present embodiment comprises the following steps:
[0038](1) Sodium carbonate is dissolved in deionized water, and preparation obtains the sodium carbonate solution that carbonate ion concentration is 0.1mol / L; Calcium chloride is dissolved in deionized water, and preparation obtains calcium ion concentration and is the chlorine of 0.12mol / L Calcium solution, ready for use after preparation;
[0039] (2) Dissolving folic acid-modified hyaluronic acid in deionized water to prepare a 2% hyaluronic acid solution by mass, which is prepared for later use;
[0040] (3) dissolving insulin in a buffered aqueous solution with pH=2.0, preparing an insulin solution with a concentration of 0.01mol / L, and then adjusting the pH of the insulin solution to 8.0 through the buffer;
[0041] (4) Prepare the oil phase containing surfactant, disperse surfactant sorbitan fatty acid ester (...
Embodiment 3
[0046] The calcium carbonate / hyaluronic acid compound insulin drug carrier that embodiment 1, embodiment 2 make, simple insulin, insulin are loaded on the calcium carbonate nanoparticle and carry out the simulation experiment in the gastric juice, the insulin in the above four kinds of materials is equivalent , the loading amount of insulin is 0.3μg, the four kinds of materials are mixed with 3mL of simulated gastric acid solution with pH=1.2, the simulated gastric acid solution contains pepsin with a mass concentration of 3g / L, after incubation at 37°C for 30min, 0.2mL of 0.1mol / L NaOH terminates the activity of pepsin. Figure 7 It shows the retention effect of insulin against pepsin under different conditions. Pure insulin is completely dissolved by pepsin. Insulin loaded on calcium carbonate nanoparticles can improve the anti-pepsin effect; calcium carbonate nanocarriers are coated with hyaluronic acid It can delay the destruction of the carrier and drug molecules by diges...
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
| thickness | aaaaa | aaaaa |
| thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 